Literature DB >> 31398712

ANNIVERSARY REVIEW: Octreotide, 40 years later.

Steven W J Lamberts1, Leo J Hofland1.   

Abstract

Octreotide remains 40 years after its development a drug, which is commonly used in the treatment of acromegaly and GEP-NETs. Very little innovation that competes with this drug occurred over this period. This review discusses several aspects of 40 years of clinical use of octreotide, including the application of radiolabeled forms of the peptide.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31398712     DOI： 10.1530/EJE-19-0074

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN： 0804-4643            Impact factor:   6.664


  13 in total

1.  Radioligand Theranostics in the Management of Neuroendocrine Tumors.

Authors:  Alan G Harris; Aaron I Vinik; Thomas M OʼDorisio; M Sue OʼDorisio
Journal:  Pancreas       Date:  2020 May/Jun       Impact factor: 3.327

Review 2.  Mass Spectrometry Approaches Empowering Neuropeptide Discovery and Therapeutics.

Authors:  Krishna D B Anapindi; Elena V Romanova; James W Checco; Jonathan V Sweedler
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

3.  Structural insights into the activation of somatostatin receptor 2 by cyclic SST analogues.

Authors:  Qing Bo; Fan Yang; Yingge Li; Xianyu Meng; Huanhuan Zhang; Yingxin Zhou; Shenglong Ling; Demeng Sun; Pei Lv; Lei Liu; Pan Shi; Changlin Tian
Journal:  Cell Discov       Date:  2022-05-20       Impact factor: 38.079

Review 4.  Multidisciplinary management of acromegaly: A consensus.

Authors:  Andrea Giustina; Garni Barkhoudarian; Albert Beckers; Anat Ben-Shlomo; Nienke Biermasz; Beverly Biller; Cesar Boguszewski; Marek Bolanowski; Jens Bollerslev; Vivien Bonert; Marcello D Bronstein; Michael Buchfelder; Felipe Casanueva; Philippe Chanson; David Clemmons; Maria Fleseriu; Anna Maria Formenti; Pamela Freda; Monica Gadelha; Eliza Geer; Mark Gurnell; Anthony P Heaney; Ken K Y Ho; Adriana G Ioachimescu; Steven Lamberts; Edward Laws; Marco Losa; Pietro Maffei; Adam Mamelak; Moises Mercado; Mark Molitch; Pietro Mortini; Alberto M Pereira; Stephan Petersenn; Kalmon Post; Manuel Puig-Domingo; Roberto Salvatori; Susan L Samson; Ilan Shimon; Christian Strasburger; Brooke Swearingen; Peter Trainer; Mary L Vance; John Wass; Margaret E Wierman; Kevin C J Yuen; Maria Chiara Zatelli; Shlomo Melmed
Journal:  Rev Endocr Metab Disord       Date:  2020-09-10       Impact factor: 6.514

5.  Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.

Authors:  Sophie E Aapkes; Robbert J de Haas; Lucas H P Bernts; Charles J Blijdorp; Sosha E I Dekker; Maatje D A van Gastel; Esther Meijer; Abigail Veldman; Joost P H Drenth; Ron T Gansevoort
Journal:  Drugs R D       Date:  2021-03-29

6.  A Pituitary Society update to acromegaly management guidelines.

Authors:  Maria Fleseriu; Beverly M K Biller; Pamela U Freda; Monica R Gadelha; Andrea Giustina; Laurence Katznelson; Mark E Molitch; Susan L Samson; Christian J Strasburger; A J van der Lely; Shlomo Melmed
Journal:  Pituitary       Date:  2020-10-20       Impact factor: 4.107

7.  Preventive and therapeutic significance of octreotide combined with lansoprazole on post-ERCP pancreatitis and its effect on serum amylase, inflammatory factors and immune function.

Authors:  Zhiliang Chen; Hong Fu; Jianfeng Fang; Jianhui Yang; Xin Zhu; Bingxiang Cheng; Tiannv Ding
Journal:  Exp Ther Med       Date:  2021-01-22       Impact factor: 2.447

8.  Octreotide-mediated neurofunctional recovery in rats following traumatic brain injury. Role of H2S, Nrf2 and TNF-α.

Authors:  Jie Zhou; Li Cao; Xia Feng; Baosheng Zhou; Linshan Li
Journal:  Acta Cir Bras       Date:  2022-02-23       Impact factor: 1.388

Review 9.  Therapeutic peptides: current applications and future directions.

Authors:  Lei Wang; Nanxi Wang; Wenping Zhang; Xurui Cheng; Zhibin Yan; Gang Shao; Xi Wang; Rui Wang; Caiyun Fu
Journal:  Signal Transduct Target Ther       Date:  2022-02-14

Review 10.  The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?

Authors:  Liliana Montella; Margaret Ottaviano; Rocco Morra; Erica Pietroluongo; Pietro De Placido; Marianna Tortora; Chiara Sorrentino; Gaetano Facchini; Sabino De Placido; Mario Giuliano; Giovannella Palmieri
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.